287 related articles for article (PubMed ID: 6347538)
1. GIP, incretin and gastrointestinal disease.
Lauritsen KB
Dan Med Bull; 1983 Jun; 30(4):205-14. PubMed ID: 6347538
[No Abstract] [Full Text] [Related]
2. [Gastric inhibitory polypeptide (GIP), incretin and gastrointestinal diseases].
Levy N; Stermer E
Harefuah; 1984 May; 106(9):427-9. PubMed ID: 6469122
[No Abstract] [Full Text] [Related]
3. Gastric inhibitory polypeptide.
Brown JC
Monogr Endocrinol; 1982; 24():III-XI, 1-88. PubMed ID: 6214707
[No Abstract] [Full Text] [Related]
4. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
5. [Endocrine system of the gastrointestinal tract. Pathophysiology with a clinical view].
Skrha J
Vnitr Lek; 2004 May; 50(5):392-8. PubMed ID: 15305639
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal peptides--rôle in pathophysiology and disease.
Creutzfeldt W
Scand J Gastroenterol Suppl; 1982; 77():7-20. PubMed ID: 6750831
[TBL] [Abstract][Full Text] [Related]
7. Extrapancreatic effects of GIP and GLP-1.
Vella A; Rizza RA
Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal hormones: some thoughts about clinical applications.
Grossman MI
Scand J Gastroenterol; 1972; 7(2):97-104. PubMed ID: 4553653
[No Abstract] [Full Text] [Related]
9. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
[TBL] [Abstract][Full Text] [Related]
10. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
Lauritsen KB; Lauritzen JB; Christensen KC
Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
[TBL] [Abstract][Full Text] [Related]
11. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
Meier JJ; Nauck MA
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal peptides and insulin secretion.
Ebert R; Creutzfeldt W
Diabetes Metab Rev; 1987 Jan; 3(1):1-26. PubMed ID: 3552520
[No Abstract] [Full Text] [Related]
13. [The intestinal hormone glucagon-like peptide 1 (GLP-1): from experiment to the clinic].
Göke B; Fehmann HC; Schirra J; Hareter A; Göke R
Z Gastroenterol; 1997 Apr; 35(4):285-94. PubMed ID: 9221612
[TBL] [Abstract][Full Text] [Related]
14. On the physiology of GIP and GLP-1.
Holst JJ
Horm Metab Res; 2004; 36(11-12):747-54. PubMed ID: 15655703
[TBL] [Abstract][Full Text] [Related]
15. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
16. What do we know about the secretion and degradation of incretin hormones?
Deacon CF
Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431
[TBL] [Abstract][Full Text] [Related]
17. The biology of incretin hormones.
Drucker DJ
Cell Metab; 2006 Mar; 3(3):153-65. PubMed ID: 16517403
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical localization of glucagonlike and gastric inhibitory polypeptidelike peptides in the pancreatic islets and gastrointestinal tract.
Smith PH
Am J Anat; 1983 Sep; 168(1):109-18. PubMed ID: 6356867
[TBL] [Abstract][Full Text] [Related]
19. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
[TBL] [Abstract][Full Text] [Related]
20. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
